Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents
Inflammation is an important and appropriate host response to infection or injury. However, dysregulation of this response, with resulting persistent or inappropriate inflammation, underlies a broad range of pathological processes, from inflammatory dermatoses to type 2 diabetes and cancer. As such,...
Saved in:
Main Authors: | Christopher J. Hall (Author), Sophie M. Wicker (Author), An-Tzu Chien (Author), Alisha Tromp (Author), Lisa M. Lawrence (Author), Xueying Sun (Author), Geoffrey W. Krissansen (Author), Kathryn E. Crosier (Author), Philip S. Crosier (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish
by: Stefan H. Oehlers, et al.
Published: (2011) -
Retinoic acid suppresses intestinal mucus production and exacerbates experimental enterocolitis
by: Stefan H. Oehlers, et al.
Published: (2012) -
Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19
by: Piero Sestili, et al.
Published: (2020) -
Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model
by: Raghda T. Abdel-Latif, et al.
Published: (2022) -
Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
by: Medi Kori, et al.
Published: (2022)